[go: up one dir, main page]

FI921473L - Method for preparing therapeutically useful benzimidazole derivatives - Google Patents

Method for preparing therapeutically useful benzimidazole derivatives Download PDF

Info

Publication number
FI921473L
FI921473L FI921473A FI921473A FI921473L FI 921473 L FI921473 L FI 921473L FI 921473 A FI921473 A FI 921473A FI 921473 A FI921473 A FI 921473A FI 921473 L FI921473 L FI 921473L
Authority
FI
Finland
Prior art keywords
therapeutically useful
benzimidazole derivatives
preparing therapeutically
useful benzimidazole
preparing
Prior art date
Application number
FI921473A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI921473A0 (en
FI99112B (en
FI99112C (en
Inventor
Maria Rosa Cuberes-Altisent
Constansa Jordi Frigola
Corominas Juan Pares
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of FI921473A0 publication Critical patent/FI921473A0/en
Publication of FI921473L publication Critical patent/FI921473L/en
Publication of FI99112B publication Critical patent/FI99112B/en
Application granted granted Critical
Publication of FI99112C publication Critical patent/FI99112C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI921473A 1991-04-05 1992-04-03 Process for the preparation of therapeutically useful benzimidazole derivatives FI99112C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9104171A FR2674856B1 (en) 1991-04-05 1991-04-05 NOVEL NON - SEDATIVE ANTIHISTAMINS, DERIVATIVES OF BENZIMIDAZOLE, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.

Publications (4)

Publication Number Publication Date
FI921473A0 FI921473A0 (en) 1992-04-03
FI921473L true FI921473L (en) 1992-10-06
FI99112B FI99112B (en) 1997-06-30
FI99112C FI99112C (en) 1997-10-10

Family

ID=9411523

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921473A FI99112C (en) 1991-04-05 1992-04-03 Process for the preparation of therapeutically useful benzimidazole derivatives

Country Status (28)

Country Link
US (1) US5214040A (en)
EP (1) EP0507696B1 (en)
JP (1) JP3060054B2 (en)
KR (1) KR970011298B1 (en)
CN (1) CN1028367C (en)
AT (1) ATE126228T1 (en)
AU (1) AU647904B2 (en)
BG (1) BG60678B1 (en)
BR (1) BR1100983A (en)
CA (1) CA2065061A1 (en)
CZ (1) CZ279506B6 (en)
DE (1) DE69203911T2 (en)
DK (1) DK0507696T3 (en)
ES (1) ES2046110B1 (en)
FI (1) FI99112C (en)
FR (1) FR2674856B1 (en)
GR (1) GR3017643T3 (en)
HU (1) HU214316B (en)
IL (1) IL101483A (en)
IS (1) IS1639B (en)
MX (1) MX9201556A (en)
NO (1) NO179552C (en)
NZ (1) NZ242208A (en)
PL (1) PL167720B1 (en)
RO (1) RO109198B1 (en)
RU (1) RU2099336C1 (en)
TW (1) TW208003B (en)
YU (1) YU48826B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264456B1 (en) * 1993-05-14 1996-09-23 Dompe Farmaceutici Spa DERIVATIVES OF PHARMACOLOGICALLY ACTIVE 2- (BENZIMIDAZOL-2-IL) -1,3-DIAMINOPROPANE.
FR2727865B1 (en) * 1994-12-08 1997-07-18 Esteve Labor Dr USE OF 2- (4- (AZOLYBUTYL) -PIPERAZINYL- (METHYL)) - BENZIMIDAZOLE DERIVATIVES AND THEIR SALTS FOR THE PREPARATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OR PROPHYLAXIS OF ASTHMA
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
AU4867496A (en) * 1995-02-15 1996-09-04 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
FR2731618B1 (en) * 1995-03-14 1997-08-01 Esteve Labor Dr TOPICAL OPHTHALMIC COMPOSITION COMPRISING A DERIVATIVE OF 2- (4- (AZOLYLBUTYL) -PIPERAZINYL-METHYL) -BENZIMIDAZOLE, IN PARTICULAR FOR THE TREATMENT OF ALLERGIC CONJUNCTIVITY
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
IL139828A0 (en) * 1998-05-22 2002-02-10 Avanir Pharmaceuticals COMPOUNDS HAVING IgE AFFECTING PROPERTIES
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
CZ304346B6 (en) * 2000-01-19 2014-03-19 Cadila Healthcare Ltd. Substituted pyrrole derivative exhibiting hypolipidemic and hypocholesteremic activity , process for its preparation and pharmaceutical composition containing thereof
CA2427156A1 (en) * 2000-10-31 2003-04-28 Basf Drucksysteme Gmbh Use of hyperbranched polyurethanes for producing printing inks
IL157029A0 (en) * 2001-02-02 2004-02-08 Bristol Myers Squibb Co Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same
WO2003060475A2 (en) * 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
RU2288917C2 (en) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOL-2-YL]-PIPERIDINYL]ETHYL]-α,α-DIMETHYLBENZENEACETIC ACID, METHOD FOR ITS PREPARING, PHARMACEUTICAL PREPARATION BASED ON THEREOF AND ITS USING
MX2007002324A (en) * 2004-09-03 2007-05-11 Yuhan Corp Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof.
CN101089000B (en) 2006-06-16 2011-01-05 北京大学 Spiro piperazine quaternary ammonium salt compound and its preparation method and application
KR20120026534A (en) * 2009-06-11 2012-03-19 시에나 바이오테크 에스.피.에이. Hedgehog pathway antagonists and therapeutic applications thereof
CA2895285C (en) * 2012-12-27 2021-03-30 Alzprotect Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
DE3336409A1 (en) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg CHINAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US5010075A (en) * 1987-04-24 1991-04-23 Syntex Pharmaceuticals Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
FR2665161B1 (en) * 1990-07-26 1992-11-27 Esteve Labor Dr NOVEL BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.

Also Published As

Publication number Publication date
IS1639B (en) 1997-03-25
RO109198B1 (en) 1994-12-30
DE69203911T2 (en) 1995-12-07
JP3060054B2 (en) 2000-07-04
YU33692A (en) 1995-03-27
IL101483A (en) 1995-12-08
NO179552B (en) 1996-07-22
TW208003B (en) 1993-06-21
FI921473A0 (en) 1992-04-03
NO921315D0 (en) 1992-04-03
AU1397992A (en) 1992-10-08
CA2065061A1 (en) 1992-10-06
IL101483A0 (en) 1992-12-30
BR1100983A (en) 1999-10-13
NO921315L (en) 1992-10-06
FI99112B (en) 1997-06-30
RU2099336C1 (en) 1997-12-20
ATE126228T1 (en) 1995-08-15
AU647904B2 (en) 1994-03-31
PL294101A1 (en) 1992-11-30
JPH0597846A (en) 1993-04-20
FI99112C (en) 1997-10-10
EP0507696A1 (en) 1992-10-07
NZ242208A (en) 1993-10-26
CN1028367C (en) 1995-05-10
CS101792A3 (en) 1992-10-14
KR970011298B1 (en) 1997-07-09
HUT60732A (en) 1992-10-28
DK0507696T3 (en) 1995-09-18
KR920019781A (en) 1992-11-20
GR3017643T3 (en) 1996-01-31
HU214316B (en) 1998-03-02
HU9201145D0 (en) 1992-06-29
BG96180A (en) 1993-12-24
MX9201556A (en) 1992-10-01
PL167720B1 (en) 1995-10-31
DE69203911D1 (en) 1995-09-14
ES2046110B1 (en) 1994-08-01
EP0507696B1 (en) 1995-08-09
US5214040A (en) 1993-05-25
FR2674856A1 (en) 1992-10-09
NO179552C (en) 1996-10-30
IS3832A (en) 1992-10-06
CZ279506B6 (en) 1995-05-17
FR2674856B1 (en) 1993-07-30
BG60678B1 (en) 1995-12-29
ES2046110A1 (en) 1994-01-16
YU48826B (en) 2002-03-18
CN1065460A (en) 1992-10-21

Similar Documents

Publication Publication Date Title
FI921473L (en) Method for preparing therapeutically useful benzimidazole derivatives
FI905941A7 (en) Method for preparing therapeutically useful heterocyclic 2-acylaminothiazole derivatives
FI893433A7 (en) Method for preparing therapeutically useful heterocyclic compounds
FI890282L (en) Method for preparing therapeutically useful 23,24-didehydro-25-hydroxycalciferol derivatives
FI951591L (en) Method for preparing taxane derivatives
NO180749C (en) Analogous Process for Preparing Therapeutically Active Benzimidazole Substituted Derivatives
FI894217L (en) Method for preparing 1-adamantane derivatives
FI890842A7 (en) Method for preparing therapeutically useful stilbene derivatives
FI892182A7 (en) Method for preparing therapeutically useful chroman derivatives
FI943643A7 (en) Method for preparing taxane derivatives
FI913614L (en) Method for preparing therapeutically useful N-sulfonyl indoline derivatives
FI940769L (en) Process for preparing 2-aminoazole derivatives
FI930150L (en) Method for preparing therapeutically active indole derivatives
FI890283A7 (en) Method for preparing therapeutically useful 25-hydroxyvitamin D derivatives
FI894803L (en) Method for preparing therapeutically useful quinolinone derivatives
FI924642L (en) Method for preparing therapeutically active 3-indolylthioacetate derivatives
FI892948A7 (en) Method for preparing therapeutically useful chroman derivatives
FI923498A7 (en) Method for preparing 3-deoxymannosamine derivatives
FI890257A7 (en) Method for preparing therapeutically useful pyridine derivatives
FI940280L (en) Process for preparing demethylepipodophyllotoxin
FI893003L (en) Method for preparing novel therapeutically useful neplanosin derivatives
FI916058A7 (en) Method for preparing therapeutically active dihydrobenzofurancarboxamides
FI911420L (en) Method for preparing therapeutically useful compounds
FI911701L (en) Process for preparing therapeutically useful 2-substituted alkyl-3-carboxycarbapenems
FI893345A7 (en) Method for preparing novel therapeutically useful pyridazinone derivatives

Legal Events

Date Code Title Description
BB Publication of examined application